Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	alpha-glucosidase activity	MGAM AGL MGAM2	1.66e-05	7	158	3	GO:0090599
GeneOntologyMolecularFunction	very long-chain fatty acid-CoA ligase activity	SLC27A5 SLC27A3 SLC27A2	5.60e-05	10	158	3	GO:0031957
GeneOntologyMolecularFunction	glucan 1,4-alpha-glucosidase activity	MGAM MGAM2	6.22e-05	2	158	2	GO:0004339
GeneOntologyMolecularFunction	cholate-CoA ligase activity	SLC27A5 SLC27A2	6.22e-05	2	158	2	GO:0047747
GeneOntologyMolecularFunction	actin filament binding	MYH9 IQGAP2 MYO7A PSTPIP1 FMNL2 TULP1 MYO5C MYO1F FMNL1	8.38e-05	227	158	9	GO:0051015
GeneOntologyMolecularFunction	long-chain fatty acid-CoA ligase activity	SLC27A5 SLC27A3 SLC27A2	2.06e-04	15	158	3	GO:0004467
GeneOntologyMolecularFunction	glucosidase activity	MGAM AGL MGAM2	2.06e-04	15	158	3	GO:0015926
GeneOntologyMolecularFunction	microfilament motor activity	MYH9 MYO7A MYO5C MYO1F	2.26e-04	38	158	4	GO:0000146
GeneOntologyMolecularFunction	phosphorylase kinase activity	PHKA1 PHKA2	3.69e-04	4	158	2	GO:0004689
GeneOntologyMolecularFunction	ATP-dependent activity	MYH9 MYO7A SMCHD1 ATP10A MYO5C EIF4A2 MOV10L1 ATP6V0A4 MYO1F AQR DYNC1I2 SLC27A5 SLC27A3 SLC27A2	3.83e-04	614	158	14	GO:0140657
GeneOntologyMolecularFunction	calmodulin binding	CACNA1C MYH9 IQGAP2 MYO7A MYO5C PHKA1 PHKA2 MYO1F	5.02e-04	230	158	8	GO:0005516
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	MGAM MGAM2	6.13e-04	5	158	2	GO:0004558
GeneOntologyMolecularFunction	transcription coregulator binding	CREB1 STAT6 ZBTB7A NR5A2 ATXN3 NFYA	8.76e-04	140	158	6	GO:0001221
GeneOntologyMolecularFunction	fatty acid ligase activity	SLC27A5 SLC27A3 SLC27A2	1.11e-03	26	158	3	GO:0015645
GeneOntologyMolecularFunction	CoA-ligase activity	SLC27A5 SLC27A3 SLC27A2	1.24e-03	27	158	3	GO:0016405
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	PCDHGB2 PCDHGA5 FAT3 PCDHB13 PCDHB8 AMIGO1 PCDHB18P CELSR1 PKD1 PCDHGA8	1.85e-06	187	158	10	GO:0007156
GeneOntologyBiologicalProcess	import into cell	NPC1 EHBP1 CACNA1C CACNA1F MYH9 HCN4 MYO7A SLC43A1 ITGA2 PSTPIP1 INPP5F CUBN SLC1A7 TULP1 PTPRJ MYO1F DMBT1 HEATR5B RAB1A RAB5B SLC27A5 SLC27A2	2.44e-05	1074	158	22	GO:0098657
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	PCDHGB2 PCDHGA5 FAT3 PCDHB13 PCDHB8 AMIGO1 PCDHB18P CELSR1 PKD1 TENM1 PCDHGA8	3.07e-05	313	158	11	GO:0098742
GeneOntologyCellularComponent	photoreceptor outer segment	CACNA1F IFT140 MYO7A PCDHB13 PCDHB8 TULP1	2.00e-04	111	158	6	GO:0001750
GeneOntologyCellularComponent	microvillus	ERBB2 IQGAP2 MYO7A NFASC CUBN MYO1F	3.48e-04	123	158	6	GO:0005902
GeneOntologyCellularComponent	photoreceptor connecting cilium	IFT140 MYO7A PCDHB13 PCDHB8	4.72e-04	48	158	4	GO:0032391
GeneOntologyCellularComponent	phosphorylase kinase complex	PHKA1 PHKA2	5.59e-04	5	158	2	GO:0005964
GeneOntologyCellularComponent	equatorial microtubule organizing center	TUBGCP5 TUBGCP3	5.59e-04	5	158	2	GO:0000923
GeneOntologyCellularComponent	photoreceptor cell cilium	CACNA1F IFT140 MYO7A PCDHB13 PCDHB8 TULP1	6.66e-04	139	158	6	GO:0097733
GeneOntologyCellularComponent	eukaryotic translation initiation factor 2 complex	EIF2S3B EIF2S3	8.35e-04	6	158	2	GO:0005850
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	NPC1 KDELR3 MGAM ERBB2 IQGAP2 PLEKHF2 NFASC INPP5F CUBN PTPRB PTPRJ PLEKHM2 SNX25 ATP6V0A4 PKD1 DNAJC5 DMBT1 RAB1A RAB5B SLC27A2 MCOLN2	8.65e-04	1307	158	21	GO:0030659
GeneOntologyCellularComponent	secretory granule membrane	MGAM IQGAP2 NFASC PTPRB PTPRJ DNAJC5 DMBT1 RAB5B SLC27A2	9.17e-04	329	158	9	GO:0030667
GeneOntologyCellularComponent	vesicle membrane	NPC1 KDELR3 MGAM ERBB2 IQGAP2 PLEKHF2 NFASC INPP5F CUBN PTPRB PTPRJ PLEKHM2 SNX25 ATP6V0A4 PKD1 DNAJC5 DMBT1 RAB1A RAB5B SLC27A2 MCOLN2	1.03e-03	1325	158	21	GO:0012506
GeneOntologyCellularComponent	myosin complex	MYH9 MYO7A MYO5C MYO1F	1.04e-03	59	158	4	GO:0016459
GeneOntologyCellularComponent	protein complex involved in cell adhesion	TNC LAMA2 ITGA2 ITGB8	1.04e-03	59	158	4	GO:0098636
GeneOntologyCellularComponent	9+0 non-motile cilium	CACNA1F IFT140 MYO7A PCDHB13 PCDHB8 TULP1	1.10e-03	153	158	6	GO:0097731
GeneOntologyCellularComponent	actomyosin contractile ring	MYH9 PSTPIP1	1.16e-03	7	158	2	GO:0005826
Domain	Cadherin_C	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHGA8	2.61e-05	42	157	5	IPR032455
Domain	Cadherin_C_2	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHGA8	2.61e-05	42	157	5	PF16492
Domain	Cadherin_CS	PCDHGB2 PCDHGA5 FAT3 PCDHB13 PCDHB8 CELSR1 PCDHGA8	3.77e-05	109	157	7	IPR020894
Domain	CADHERIN_1	PCDHGB2 PCDHGA5 FAT3 PCDHB13 PCDHB8 CELSR1 PCDHGA8	4.75e-05	113	157	7	PS00232
Domain	Cadherin	PCDHGB2 PCDHGA5 FAT3 PCDHB13 PCDHB8 CELSR1 PCDHGA8	4.75e-05	113	157	7	PF00028
Domain	CADHERIN_2	PCDHGB2 PCDHGA5 FAT3 PCDHB13 PCDHB8 CELSR1 PCDHGA8	5.03e-05	114	157	7	PS50268
Domain	-	PCDHGB2 PCDHGA5 FAT3 PCDHB13 PCDHB8 CELSR1 PCDHGA8	5.03e-05	114	157	7	2.60.40.60
Domain	CA	PCDHGB2 PCDHGA5 FAT3 PCDHB13 PCDHB8 CELSR1 PCDHGA8	5.32e-05	115	157	7	SM00112
Domain	Cadherin-like	PCDHGB2 PCDHGA5 FAT3 PCDHB13 PCDHB8 CELSR1 PCDHGA8	5.62e-05	116	157	7	IPR015919
Domain	Cadherin	PCDHGB2 PCDHGA5 FAT3 PCDHB13 PCDHB8 CELSR1 PCDHGA8	6.27e-05	118	157	7	IPR002126
Domain	6-hairpin_glycosidase-like	PHKA1 PHKA2 AGL	1.57e-04	13	157	3	IPR008928
Domain	EGF	TNC FAT3 LAMA2 CUBN ITGB8 CELSR1 UMODL1 TENM1 VWA2	1.71e-04	235	157	9	SM00181
Domain	FN3	COL6A3 TNC NFASC CRLF2 PTPRB PTPRJ UMODL1 COL14A1	1.73e-04	185	157	8	SM00060
Domain	Glyco_hydro_15/PHK	PHKA1 PHKA2	2.09e-04	3	157	2	IPR011613
Domain	CAC1F_C	CACNA1C CACNA1F	2.09e-04	3	157	2	IPR031688
Domain	PHK_A/B_su	PHKA1 PHKA2	2.09e-04	3	157	2	IPR008734
Domain	Glyco_hydro_15	PHKA1 PHKA2	2.09e-04	3	157	2	PF00723
Domain	CAC1F_C	CACNA1C CACNA1F	2.09e-04	3	157	2	PF16885
Domain	Cadherin_2	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHGA8	2.17e-04	65	157	5	PF08266
Domain	Cadherin_N	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHGA8	2.17e-04	65	157	5	IPR013164
Domain	Myosin_head_motor_dom	MYH9 MYO7A MYO5C MYO1F	2.84e-04	38	157	4	IPR001609
Domain	MYOSIN_MOTOR	MYH9 MYO7A MYO5C MYO1F	2.84e-04	38	157	4	PS51456
Domain	Myosin_head	MYH9 MYO7A MYO5C MYO1F	2.84e-04	38	157	4	PF00063
Domain	MYSc	MYH9 MYO7A MYO5C MYO1F	2.84e-04	38	157	4	SM00242
Domain	FN3	COL6A3 TNC NFASC CRLF2 PTPRB PTPRJ UMODL1 COL14A1	2.85e-04	199	157	8	PS50853
Domain	EGF_1	TNC FAT3 LAMA2 CUBN ITGB8 CELSR1 UMODL1 TENM1 VWA2	3.13e-04	255	157	9	PS00022
Domain	IQ	MYH9 IQGAP2 MYO7A MYO5C MYO1F	3.28e-04	71	157	5	PF00612
Domain	AMP-bd_C	SLC27A5 SLC27A3 SLC27A2	3.63e-04	17	157	3	IPR025110
Domain	AMP-binding_C	SLC27A5 SLC27A3 SLC27A2	3.63e-04	17	157	3	PF13193
Domain	EGF-like_CS	TNC FAT3 LAMA2 CUBN ITGB8 CELSR1 UMODL1 TENM1 VWA2	3.71e-04	261	157	9	IPR013032
Domain	FN3_dom	COL6A3 TNC NFASC CRLF2 PTPRB PTPRJ UMODL1 COL14A1	3.95e-04	209	157	8	IPR003961
Domain	EGF_2	TNC FAT3 LAMA2 CUBN ITGB8 CELSR1 UMODL1 TENM1 VWA2	4.15e-04	265	157	9	PS01186
Domain	Gal_mutarotase_N	MGAM MGAM2	4.17e-04	4	157	2	IPR031727
Domain	VDCC_L_a1su	CACNA1C CACNA1F	4.17e-04	4	157	2	IPR005446
Domain	NtCtMGAM_N	MGAM MGAM2	4.17e-04	4	157	2	PF16863
Domain	IQ	MYH9 IQGAP2 MYO7A MYO5C MYO1F	6.03e-04	81	157	5	SM00015
Domain	VWFA	COL6A3 ITGA2 ITGB8 COL14A1 VWA2	6.38e-04	82	157	5	PS50234
Domain	Spc97_Spc98	TUBGCP5 TUBGCP3	6.91e-04	5	157	2	PF04130
Domain	GCP	TUBGCP5 TUBGCP3	6.91e-04	5	157	2	IPR007259
Domain	VWA	COL6A3 ITGA2 ITGB8 COL14A1 VWA2	7.12e-04	84	157	5	SM00327
Domain	IQ_motif_EF-hand-BS	MYH9 IQGAP2 MYO7A MYO5C MYO1F	9.74e-04	90	157	5	IPR000048
Domain	Glyco_hydro_31_AS	MGAM MGAM2	1.03e-03	6	157	2	IPR030458
Domain	IQ	MYH9 IQGAP2 MYO7A MYO5C MYO1F	1.13e-03	93	157	5	PS50096
Domain	EGF-like_dom	TNC FAT3 LAMA2 CUBN CELSR1 UMODL1 TENM1 VWA2	1.24e-03	249	157	8	IPR000742
Domain	VWA	COL6A3 ITGA2 COL14A1 VWA2	1.26e-03	56	157	4	PF00092
Domain	AMP-binding_CS	SLC27A5 SLC27A3 SLC27A2	1.31e-03	26	157	3	IPR020845
Domain	Laminin_G	FAT3 LAMA2 CELSR1 COL14A1	1.43e-03	58	157	4	IPR001791
Domain	Glyco_hydro_31	MGAM MGAM2	1.43e-03	7	157	2	IPR000322
Domain	PKD	PKD1 SORCS3	1.43e-03	7	157	2	PF00801
Domain	Glyco_hydro_31	MGAM MGAM2	1.43e-03	7	157	2	PF01055
Domain	Ca_chan_IQ	CACNA1C CACNA1F	1.43e-03	7	157	2	SM01062
Domain	Ca_chan_IQ	CACNA1C CACNA1F	1.43e-03	7	157	2	PF08763
Domain	VDCC_a1su_IQ	CACNA1C CACNA1F	1.43e-03	7	157	2	IPR014873
Domain	GPHH	CACNA1C CACNA1F	1.43e-03	7	157	2	PF16905
Domain	GPHH_dom	CACNA1C CACNA1F	1.43e-03	7	157	2	IPR031649
Domain	GLYCOSYL_HYDROL_F31_1	MGAM MGAM2	1.43e-03	7	157	2	PS00129
Domain	VWF_A	COL6A3 ITGA2 ITGB8 COL14A1 VWA2	1.49e-03	99	157	5	IPR002035
Domain	AMP_BINDING	SLC27A5 SLC27A3 SLC27A2	1.64e-03	28	157	3	PS00455
Domain	DAD_dom	FMNL2 FMNL1	1.90e-03	8	157	2	IPR014767
Domain	6hp_glycosidase	PHKA1 PHKA2	1.90e-03	8	157	2	IPR012341
Domain	DAD	FMNL2 FMNL1	1.90e-03	8	157	2	PS51231
Domain	Trefoil	MGAM MGAM2	1.90e-03	8	157	2	PF00088
Domain	-	PHKA1 PHKA2	1.90e-03	8	157	2	1.50.10.10
Domain	AMP-binding	SLC27A5 SLC27A3 SLC27A2	2.00e-03	30	157	3	PF00501
Domain	AMP-dep_Synth/Lig	SLC27A5 SLC27A3 SLC27A2	2.00e-03	30	157	3	IPR000873
Domain	Drf_GBD	FMNL2 FMNL1	2.43e-03	9	157	2	PF06371
Domain	Drf_FH3	FMNL2 FMNL1	2.43e-03	9	157	2	PF06367
Domain	P_TREFOIL_2	MGAM MGAM2	2.43e-03	9	157	2	PS51448
Domain	FH3_dom	FMNL2 FMNL1	2.43e-03	9	157	2	IPR010472
Domain	GTPase-bd	FMNL2 FMNL1	2.43e-03	9	157	2	IPR010473
Domain	Drf_FH3	FMNL2 FMNL1	2.43e-03	9	157	2	SM01139
Domain	Drf_GBD	FMNL2 FMNL1	2.43e-03	9	157	2	SM01140
Domain	PD	MGAM MGAM2	2.43e-03	9	157	2	SM00018
Domain	fn3	TNC NFASC PTPRB PTPRJ UMODL1 COL14A1	2.50e-03	162	157	6	PF00041
Domain	VDCCAlpha1	CACNA1C CACNA1F	3.02e-03	10	157	2	IPR002077
Domain	-	COL6A3 ITGB8 COL14A1 VWA2	3.50e-03	74	157	4	3.40.50.410
Domain	Cadherin_tail	PCDHGB2 PCDHGA5 PCDHGA8	3.67e-03	37	157	3	PF15974
Domain	Cadherin_CBD	PCDHGB2 PCDHGA5 PCDHGA8	3.67e-03	37	157	3	IPR031904
Domain	-	MGAM MGAM2	3.67e-03	11	157	2	4.10.110.10
Domain	GBD/FH3_dom	FMNL2 FMNL1	3.67e-03	11	157	2	IPR014768
Domain	GBD_FH3	FMNL2 FMNL1	3.67e-03	11	157	2	PS51232
Domain	PKD	PKD1 SORCS3	3.67e-03	11	157	2	PS50093
Domain	PKD_dom	PKD1 SORCS3	3.67e-03	11	157	2	IPR000601
Domain	PKD_channel	PKD1 MCOLN2	3.67e-03	11	157	2	PF08016
Domain	PKD1_2_channel	PKD1 MCOLN2	3.67e-03	11	157	2	IPR013122
Domain	-	PKD1 SORCS3	3.67e-03	11	157	2	2.60.40.670
Domain	EGF_CA	FAT3 CUBN CELSR1 UMODL1 VWA2	3.71e-03	122	157	5	SM00179
Domain	EGF_3	TNC FAT3 CUBN CELSR1 UMODL1 TENM1 VWA2	3.78e-03	235	157	7	PS50026
Domain	LAM_G_DOMAIN	FAT3 LAMA2 CELSR1	3.96e-03	38	157	3	PS50025
Domain	EGF-like_Ca-bd_dom	FAT3 CUBN CELSR1 UMODL1 VWA2	3.97e-03	124	157	5	IPR001881
Domain	P_trefoil_dom	MGAM MGAM2	4.38e-03	12	157	2	IPR000519
Domain	Laminin_G_2	FAT3 LAMA2 CELSR1	4.58e-03	40	157	3	PF02210
Domain	ZP_2	UMODL1 DMBT1	5.98e-03	14	157	2	PS51034
Domain	ZP_1	UMODL1 DMBT1	5.98e-03	14	157	2	PS00682
Domain	LamG	FAT3 LAMA2 CELSR1	6.00e-03	44	157	3	SM00282
Domain	FH2	FMNL2 FMNL1	6.86e-03	15	157	2	PS51444
Domain	FH2_Formin	FMNL2 FMNL1	6.86e-03	15	157	2	IPR015425
Domain	FH2	FMNL2 FMNL1	6.86e-03	15	157	2	PF02181
Domain	Myosin_N	MYH9 MYO5C	6.86e-03	15	157	2	PF02736
Domain	Myosin_N	MYH9 MYO5C	6.86e-03	15	157	2	IPR004009
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHB18P CELSR1 PCDHGA8	4.57e-08	72	161	7	10380929
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHB18P CELSR1 PCDHGA8	7.32e-08	77	161	7	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHB18P CELSR1 PCDHGA8	9.56e-08	80	161	7	10716726
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYH9 MYO7A MYO5C MYO1F	4.27e-07	14	161	4	8022818
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHB18P PCDHGA8	7.74e-07	68	161	6	11230163
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHB18P PCDHGA8	1.28e-06	74	161	6	10817752
Pubmed	A family of fatty acid transporters conserved from mycobacterium to man.	SLC27A5 SLC27A3 SLC27A2	1.93e-06	6	161	3	9671728
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	NPC1 NSUN4 MYH9 TRIO SMCHD1 GARS1 EXOSC3 PRPF8 SLC30A7 S100A6 DST BAZ1A EIF2S3 EIF4A2 RAB1A RIOK2 G6PD RAB5B AQR XPOT	2.61e-06	1297	161	20	33545068
Pubmed	Differential expression of fatty acid transport proteins in epidermis and skin appendages.	SLC27A5 SLC27A3 SLC27A2	3.36e-06	7	161	3	16354187
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CACNA1C KDELR3 MYH9 IQGAP2 PCDHGB2 PCDHGA5 SMCHD1 GARS1 PRPF8 DST UMODL1 BAZ1A SNX25 RBMX2 EIF4A2 MARF1 TENM1 DNAJC5 RAB1A PCDHGA8 DYNC1I2	3.50e-06	1442	161	21	35575683
Pubmed	X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases.	SLC27A5 SLC27A3 SLC27A2	5.36e-06	8	161	3	15464426
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	CACNA1C GATAD2A MYO7A ITGA2 CHRNA3 PTPRB PKD1	1.59e-05	171	161	7	20201926
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SLC37A1 EHBP1 CACNA1C ERBB2 TRIO FOLH1 DPYSL5 EXOSC3 NFASC GRHL2 INTS8 ATP10A CUL5 ANKRD44 ZBTB7A PTPRB PTPRJ SH3TC1 KDM4B EVI5L	1.97e-05	1489	161	20	28611215
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	NPC1 ERBB2 VPS50 LAMA2 GRHL2 CUL5 SLC30A7 MTRF1 PKD1 FGF8 MMP1 SLC27A2 MCOLN2	2.02e-05	686	161	13	29987050
Pubmed	The expression and function of fatty acid transport protein-2 and -4 in the murine placenta.	SLC27A5 SLC27A3 SLC27A2	2.08e-05	12	161	3	22028793
Pubmed	Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids.	TNC ITGA2 ITGB8	2.08e-05	12	161	3	10090148
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	MYH9 GATAD2A IQGAP2 SMCHD1 GARS1 FBXO11 PRPF8 FMNL2 IGF2BP2 BAZ1A AGL RBMX2 TUBGCP3 MARF1 COL14A1 PAK1IP1 RAB1A RIOK2 RAB5B	2.11e-05	1371	161	19	36244648
Pubmed	β-glucan curdlan induces IL-10-producing CD4+ T cells and inhibits allergic airway inflammation.	TBX21 STAT6	2.13e-05	2	161	2	23136202
Pubmed	HER-2/neu mediates oncogenic transformation via altered CREB expression and function.	ERBB2 CREB1	2.13e-05	2	161	2	24025972
Pubmed	The multiphosphorylation domain of the phosphorylase kinase alpha M and alpha L subunits is a hotspot of differential mRNA processing and of molecular evolution.	PHKA1 PHKA2	2.13e-05	2	161	2	8226841
Pubmed	Do matrix metalloproteinase-1 and glucose-6-phosphate dehydrogenase gene polymorphisms interact in promoting lymphoma development?	MMP1 G6PD	2.13e-05	2	161	2	23485169
Pubmed	COL6A and LAMA2 Mutation Congenital Muscular Dystrophy: A Clinical and Electrophysiological Study.	COL6A3 LAMA2	2.13e-05	2	161	2	29465610
Pubmed	Early effects of cigarette smoke extract on human oral keratinocytes and carcinogenesis in head and neck squamous cell carcinoma.	ITGA2 MMP1	2.13e-05	2	161	2	32437034
Pubmed	Relationships between progesterone receptor isoforms and the HER/ErbB receptors and ligands network in 299 primary breast cancers.	ERBB2 S100A6	2.13e-05	2	161	2	22505232
Pubmed	A novel relative of the very-long-chain acyl-CoA synthetase and fatty acid transporter protein genes with a distinct expression pattern.	SLC27A5 SLC27A2	2.13e-05	2	161	2	9642112
Pubmed	Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease.	STAT6 PKD1	2.13e-05	2	161	2	22025716
Pubmed	FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase.	SLC27A5 SLC27A2	2.13e-05	2	161	2	20530735
Pubmed	Participation of two members of the very long-chain acyl-CoA synthetase family in bile acid synthesis and recycling.	SLC27A5 SLC27A2	2.13e-05	2	161	2	11980911
Pubmed	Gender-related differences in the association between concomitant amplification of AIB1 and HER2 and clinical outcomes in glioma patients.	NCOA3 ERBB2	2.13e-05	2	161	2	30153912
Pubmed	Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling.	CREB1 CUL5	2.13e-05	2	161	2	36662868
Pubmed	X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver alpha subunit of phosphorylase kinase.	PHKA1 PHKA2	2.13e-05	2	161	2	8733133
Pubmed	Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction.	ITGA2 MMP1	2.13e-05	2	161	2	11359774
Pubmed	Overexpression and Nucleolar Localization of γ-Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma.	FOLH1 TUBGCP3	2.13e-05	2	161	2	26079448
Pubmed	The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo.	FGF8 TBXT	2.13e-05	2	161	2	10518487
Pubmed	Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C.	TNC PTPRB	2.13e-05	2	161	2	11313993
Pubmed	Sphingosine-1-phosphate regulates the expression of the liver receptor homologue-1.	CREB1 NR5A2	2.13e-05	2	161	2	18191017
Pubmed	cDNA cloning of a liver isoform of the phosphorylase kinase alpha subunit and mapping of the gene to Xp22.2-p22.1, the region of human X-linked liver glycogenosis.	PHKA1 PHKA2	2.13e-05	2	161	2	1372435
Pubmed	Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability.	CACNA1C PKD1	2.13e-05	2	161	2	25888683
Pubmed	The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.	NCOA3 ERBB2	2.13e-05	2	161	2	18483252
Pubmed	HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion.	ERBB2 MMP1	2.13e-05	2	161	2	20460098
Pubmed	Role for formin-like 1-dependent acto-myosin assembly in lipid droplet dynamics and lipid storage.	MYH9 FMNL1	2.13e-05	2	161	2	28361956
Pubmed	The key regulators of adult T helper cell responses, STAT6 and T-bet, are established in early life in mice.	TBX21 STAT6	2.13e-05	2	161	2	16568497
Pubmed	Critical roles for multiple formins during cardiac myofibril development and repair.	FMNL2 FMNL1	2.13e-05	2	161	2	24430873
Pubmed	Oral feeding of Lactobacillus bulgaricus N45.10 inhibits the lung inflammation and airway remodeling in murine allergic asthma: Relevance to the Th1/Th2 cytokines and STAT6/T-bet.	TBX21 STAT6	2.13e-05	2	161	2	31178059
Pubmed	Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain.	EIF2S3B EIF2S3	2.13e-05	2	161	2	16325480
Pubmed	Structural requirements for association of neurofascin with ankyrin.	ANK1 NFASC	2.13e-05	2	161	2	9804856
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	NPC1 COL6A3 MYH9 IQGAP2 VPS50 PSMB2 CUBN ITGB8 S100A6 PTPRJ ATP6V0A4 PKD1 SCPEP1 G6PD RAB5B SLC27A2	2.16e-05	1016	161	16	19056867
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CACNA1C ANK1 MYO7A VPS50 DPYSL5 PRPF8 PTPRB G6PD MINDY1 KDM4B XPOT	2.21e-05	497	161	11	36774506
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	COL6A3 MYH9 FRMPD4 TRIO MYO7A SMCHD1 TUBGCP5 DST EIF2S3 TENM1 MMP1	2.95e-05	513	161	11	25798074
Pubmed	Ligand-activated peroxisome proliferator activated receptor gamma alters placental morphology and placental fatty acid uptake in mice.	SLC27A5 SLC27A3 SLC27A2	3.41e-05	14	161	3	17463056
Pubmed	Nuclear receptor NR5A2 is required for proper primitive streak morphogenesis.	NR5A2 FGF8 TBXT	3.41e-05	14	161	3	17075876
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CACNA1F MYH9 ANK1 MYO7A GARS1 EXOSC3 NFASC PRPF8 FMNL2 DST AGL PKD1 PIGW	4.17e-05	736	161	13	29676528
Pubmed	Overexpression of Grainyhead-like 3 causes spina bifida and interacts genetically with mutant alleles of Grhl2 and Vangl2 in mice.	GRHL2 FGF8 TBXT	4.25e-05	15	161	3	30189017
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	NPC1 HK3 IQGAP2 FBXO11 CUBN STAT6 WWC2 AP4S1 BAZ1A EIF4A2 PIGW MMP1 USF2 SLX4 MINDY1 XPOT	4.69e-05	1084	161	16	11544199
Pubmed	Prediction of the coding sequences of mouse homologues of FLJ genes: the complete nucleotide sequences of 110 mouse FLJ-homologous cDnas identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYH9 SH3TC1 MYO1F FMNL1 SLC27A3	4.86e-05	85	161	5	15449545
Pubmed	A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse.	FBXO11 CELSR1 TBXT	5.22e-05	16	161	3	10932191
Pubmed	A unique role of cohesin-SA1 in gene regulation and development.	PCDHB13 PCDHB8 PCDHB18P	5.22e-05	16	161	3	22415368
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	NSUN4 GATAD2A IQGAP2 SMCHD1 EXOSC3 FBXO11 PRPF8 IGF2BP2 BAZ1A EIF2S3 PAK1IP1 NEURL4 AQR	5.70e-05	759	161	13	35915203
Pubmed	Stat4 is critical for the balance between Th17 cells and regulatory T cells in colitis.	TBX21 STAT6	6.37e-05	3	161	2	21525389
Pubmed	Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway.	ERBB2 CUL5	6.37e-05	3	161	2	33412308
Pubmed	T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17.	TBX21 STAT6	6.37e-05	3	161	2	19050290
Pubmed	The transcriptional co-activator p/CIP (NCoA-3) is up-regulated by STAT6 and serves as a positive regulator of transcriptional activation by STAT6.	NCOA3 STAT6	6.37e-05	3	161	2	15145939
Pubmed	Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells.	ERBB2 MMP1	6.37e-05	3	161	2	18851945
Pubmed	Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex.	NCOA3 ERBB2	6.37e-05	3	161	2	24678732
Pubmed	The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease.	CREB1 ATXN3	6.37e-05	3	161	2	11572863
Pubmed	IL-4 stimulates mouse macrophages to express APRIL through p38MAPK and two different downstream molecules, CREB and Stat6.	CREB1 STAT6	6.37e-05	3	161	2	19427796
Pubmed	T-bet and STAT6 Coordinately Suppress the Development of IL-9-Mediated Atopic Dermatitis-Like Skin Inflammation in Mice.	TBX21 STAT6	6.37e-05	3	161	2	33068596
Pubmed	HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes.	NCOA3 ERBB2	6.37e-05	3	161	2	26833126
Pubmed	Fucosyltransferase 2 induces lung epithelial fucosylation and exacerbates house dust mite-induced airway inflammation.	TBX21 STAT6	6.37e-05	3	161	2	31125592
Pubmed	Human very long-chain acyl-CoA synthetase and two human homologs: initial characterization and relationship to fatty acid transport protein.	SLC27A5 SLC27A2	6.37e-05	3	161	2	10471116
Pubmed	The human liver-specific homolog of very long-chain acyl-CoA synthetase is cholate:CoA ligase.	SLC27A5 SLC27A2	6.37e-05	3	161	2	10749848
Pubmed	STAT6 inhibits T-bet-independent Th1 cell differentiation.	TBX21 STAT6	6.37e-05	3	161	2	19324016
Pubmed	Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico.	FMNL2 FMNL1	6.37e-05	3	161	2	12684686
Pubmed	Novel function of tenascin-C, a matrix protein relevant to atherosclerosis, in platelet recruitment and activation under flow.	TNC ITGA2	6.37e-05	3	161	2	20651280
Pubmed	Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.	CREB1 STAT6	6.37e-05	3	161	2	30642265
Pubmed	Distinct localization and modulation of Cav1.2 and Cav1.3 L-type Ca2+ channels in mouse sinoatrial node.	CACNA1C HCN4	6.37e-05	3	161	2	23045342
Pubmed	Glucoamylase-like domains in the alpha- and beta-subunits of phosphorylase kinase.	PHKA1 PHKA2	6.37e-05	3	161	2	12876330
Pubmed	Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.	CREB1 NR5A2	6.37e-05	3	161	2	27809310
Pubmed	KDM4B promotes DNA damage response via STAT3 signaling and is a target of CREB in colorectal cancer cells.	CREB1 KDM4B	6.37e-05	3	161	2	29633065
Pubmed	C-FLIP(L) contributes to TRAIL resistance in HER2-positive breast cancer.	ERBB2 CFLAR	6.37e-05	3	161	2	24909691
Pubmed	c-erbB2-induced disruption of matrix adhesion and morphogenesis reveals a novel role for protein kinase B as a negative regulator of alpha(2)beta(1) integrin function.	ERBB2 ITGA2	6.37e-05	3	161	2	12181354
Pubmed	Human liver-specific very-long-chain acyl-coenzyme A synthetase: cDNA cloning and characterization of a second enzymatically active protein.	SLC27A5 SLC27A2	6.37e-05	3	161	2	10479480
Pubmed	Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.	STAT6 PKD1	6.37e-05	3	161	2	29513071
Pubmed	Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP.	NCOA3 NR5A2	6.37e-05	3	161	2	15723037
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	COL6A3 TNC LAMA2 S100A6 CBLN4 COL14A1	8.25e-05	153	161	6	25037231
Pubmed	Reduction of Nipbl impairs cohesin loading locally and affects transcription but not cohesion-dependent functions in a mouse model of Cornelia de Lange Syndrome.	PCDHB13 PCDHB8 PCDHB18P	8.93e-05	19	161	3	23920377
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MYH9 IQGAP2 GARS1 EXOSC3 PRPF8 PHKA1 PHKA2 IGF2BP2 DST EIF2S3 AGL EIF4A2 SCPEP1 RAB1A G6PD DYNC1I2	9.26e-05	1149	161	16	35446349
Pubmed	The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.	PCDHB13 PCDHB8 PCDHB18P	1.05e-04	20	161	3	11322959
Pubmed	¹H NMR metabolic profiling of plasma reveals additional phenotypes in knockout mouse models.	ITGA2 AGL MINDY1	1.05e-04	20	161	3	25849460
Pubmed	β-catenin regulates Pax3 and Cdx2 for caudal neural tube closure and elongation.	CELSR1 FGF8 TBXT	1.22e-04	21	161	3	24284205
Pubmed	Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner.	NCOA3 NR5A2	1.27e-04	4	161	2	11668176
Pubmed	Beta-adrenergic-regulated phosphorylation of the skeletal muscle Ca(V)1.1 channel in the fight-or-flight response.	CACNA1C CACNA1F	1.27e-04	4	161	2	20937870
Pubmed	Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: critical importance of MEK/ERK-dependent activation of USF1/-2 and CREB transcription factors.	CREB1 USF2	1.27e-04	4	161	2	14531897
Pubmed	Isolation of cDNA clones for the catalytic gamma subunit of mouse muscle phosphorylase kinase: expression of mRNA in normal and mutant Phk mice.	PHKA1 PHKA2	1.27e-04	4	161	2	3472241
Pubmed	Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation.	CREB1 PKD1	1.27e-04	4	161	2	22570239
Pubmed	Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory.	CACNA1C CREB1	1.27e-04	4	161	2	16251435
Pubmed	Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt.	ITGA2 MMP1	1.27e-04	4	161	2	14679206
Pubmed	The integral membrane protein ITM2A, a transcriptional target of PKA-CREB, regulates autophagic flux via interaction with the vacuolar ATPase.	CREB1 ATP6V0A4	1.27e-04	4	161	2	25951193
Pubmed	NF-Y cooperates with USF1/2 to induce the hematopoietic expression of HOXB4.	NFYA USF2	1.27e-04	4	161	2	12791656
Pubmed	Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB.	EIF2S3B EIF2S3	1.27e-04	4	161	2	31836389
Cytoband	5q31	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHB18P PCDHGA8	3.48e-06	115	161	6	5q31
Cytoband	Xp22.2-p22.1	PHKA2 EIF2S3	1.21e-04	5	161	2	Xp22.2-p22.1
GeneFamily	Clustered protocadherins	PCDHGB2 PCDHGA5 PCDHB13 PCDHB8 PCDHB18P PCDHGA8	2.24e-06	64	108	6	20
GeneFamily	Fibronectin type III domain containing	TNC NFASC CRLF2 PTPRB PTPRJ COL14A1	3.98e-04	160	108	6	555
GeneFamily	Acyl-CoA synthetase family	SLC27A5 SLC27A3 SLC27A2	4.88e-04	26	108	3	40
GeneFamily	UPF1 like RNA helicases	MOV10L1 AQR	1.88e-03	11	108	2	1169
Coexpression	MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL	KDELR3 COL6A3 MYH9 TRIO TNC STK17B GARS1 LAMA2 ITGA2 TBC1D16 BAZ1A EIF2S3 MMP1 G6PD XPOT	2.12e-05	681	161	15	M39175
Coexpression	EGFR_UP.V1_DN	INPP5F EIF2S3 AGL CARF MARF1 TENM1 SLC27A3 SLC27A2	3.00e-05	196	161	8	M2633
Coexpression	BROWNE_HCMV_INFECTION_24HR_DN	COL6A3 ITGA2 CFLAR AP4S1 DST FGF8 MMP1	3.29e-05	145	161	7	M14098
Coexpression	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	INPP5F CRLF2 B4GALT5 STAT6 ANKRD44 SCPEP1 EVI5L MCOLN2	3.46e-05	200	161	8	M6035
Coexpression	GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP	NCOA3 TRIO MYO7A PRPF8 GDF3 B4GALT5 USF2 RAB1A	3.46e-05	200	161	8	M6266
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL	KDELR3 ERBB2 IQGAP2 TNC LAMA2 ITGA2 ITGB8 ZBTB7A COL14A1	4.41e-05	268	161	9	M45796
Coexpression	BROWNE_HCMV_INFECTION_48HR_DN	CACNA1C ERBB2 FRMPD4 ANK1 TRIO LAMA2 NFASC CUBN DHRS1 ATXN3 RAB5B DYNC1I2	4.58e-05	482	161	12	M12144
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SLC37A1 CACNA1F ERBB2 ITGA2 GRHL2 MYO5C WWC2 CBLN4 CELSR1 LPIN2	2.92e-09	199	160	10	a270630626df614f8605abddb7dee7c4d74f6149
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SLC37A1 CACNA1F ERBB2 ITGA2 GRHL2 MYO5C WWC2 CELSR1 LPIN2	4.38e-08	198	160	9	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CACNA1F ERBB2 ITGA2 GRHL2 MYO5C S100A6 WWC2 CELSR1 LPIN2	4.78e-08	200	160	9	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IQGAP2 STK17B SMCHD1 TBX21 PSTPIP1 ANKRD44 MYO1F FMNL1	4.50e-07	190	160	8	b772a5d281fe016f259ddda80d6f33d949dcac2b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IQGAP2 STK17B TBX21 PSTPIP1 ANKRD44 MYO1F FMNL1 MCOLN2	4.68e-07	191	160	8	d9506b88d806aadd4c2b9bf86fe994c47799e7f6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IQGAP2 STK17B TBX21 PSTPIP1 ANKRD44 MYO1F FMNL1 MCOLN2	4.68e-07	191	160	8	b42c54308abe1241cc38ddce96b9d38d07983891
ToppCell	COVID-19-lung-CD8+_T_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IQGAP2 STK17B TBX21 PSTPIP1 ANKRD44 MYO1F FMNL1 MCOLN2	4.68e-07	191	160	8	543f8ae07cc2e6950c888115a5ca9445e3c0f618
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IQGAP2 STK17B TBX21 PSTPIP1 ANKRD44 MYO1F FMNL1 MCOLN2	4.68e-07	191	160	8	9aabbc65430e2233b8f2d3fff9face7807b88b48
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	NPC1 GATAD2A TRIO TNC FMNL2 ATP10A SH3TC1 BAZ1A	4.87e-07	192	160	8	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1C COL6A3 FAT3 LAMA2 NFASC ITGA2 DST MCOLN2	5.48e-07	195	160	8	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC37A1 CACNA1F ITGA2 GRHL2 MYO5C WWC2 CELSR1 LPIN2	5.92e-07	197	160	8	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	BL\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MGAM MYH9 SMCHD1 CFLAR PTPRJ BAZ1A MYO1F FMNL1	5.92e-07	197	160	8	1acf0191fa0a25cd20bfd9ea7bf727a1555986a1
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NCOA3 STK17B FBXO11 TBC1D16 ANKRD44 DST MYO1F	5.96e-07	135	160	7	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C COL6A3 FAT3 LAMA2 ITGA2 DST COL14A1 MCOLN2	6.15e-07	198	160	8	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC37A1 CACNA1F ERBB2 ITGA2 MYO5C WWC2 CELSR1 LPIN2	6.39e-07	199	160	8	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ERBB2 ITGA2 GRHL2 MYO5C S100A6 WWC2 CELSR1 LPIN2	6.39e-07	199	160	8	1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	SLC37A1 CACNA1F ERBB2 ITGA2 GRHL2 MYO5C PHKA2 WWC2	6.63e-07	200	160	8	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CACNA1C COL6A3 TNC FAT3 LAMA2 NFASC ITGA2 DST	6.63e-07	200	160	8	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC37A1 CACNA1F ERBB2 ITGA2 MYO5C WWC2 CELSR1 LPIN2	6.63e-07	200	160	8	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CACNA1C COL6A3 TNC FAT3 LAMA2 NFASC ITGA2 DST	6.63e-07	200	160	8	a510deaada669e690329183e18df02870bd204b3
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL6A3 FAT3 LAMA2 NFASC ITGA2 DST MCOLN2	6.63e-07	200	160	8	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CACNA1C COL6A3 TNC FAT3 LAMA2 NFASC ITGA2 DST	6.63e-07	200	160	8	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	LV-16._Neuronal\|World / Chamber and Cluster_Paper	EHBP1 IQGAP2 ITGA2 ITGB8 S100A6 PTPRJ SORCS3	2.29e-06	165	160	7	6ed52cb756d21addf46c7f6c457458b01339fe04
ToppCell	LV-16._Neuronal\|LV / Chamber and Cluster_Paper	EHBP1 IQGAP2 ITGA2 ITGB8 S100A6 PTPRJ SORCS3	2.68e-06	169	160	7	a8fc8ab0f0757e939e213efb61c03cfe390bf7d2
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	EHBP1 IQGAP2 ITGA2 INPP5F ITGB8 PTPRJ SORCS3	3.13e-06	173	160	7	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	normal_Lung-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	HUS1B MYO7A TNC ITGA2 ITGB8 BBS12 SLC27A2	3.25e-06	174	160	7	e324320b52c904496e26fcecfa179b3431729ec0
ToppCell	Fetal_29-31_weeks-Immune-dendritic_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	IQGAP2 STK17B CRLF2 SH3TC1 MYO1F FMNL1 MCOLN2	3.64e-06	177	160	7	c5e829bc4594761666d65cace5a9c5d19c16f187
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1F ERBB2 ITGA2 GRHL2 MYO5C WWC2 CELSR1	4.22e-06	181	160	7	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F MGAM FRMPD4 ANK1 FOLH1 FAT3 TENM1	4.70e-06	184	160	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F MGAM FRMPD4 ANK1 FOLH1 FAT3 TENM1	4.70e-06	184	160	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F MGAM FRMPD4 ANK1 FOLH1 FAT3 TENM1	4.70e-06	184	160	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERBB2 ITGA2 GRHL2 MYO5C WWC2 CELSR1 LPIN2	5.04e-06	186	160	7	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C COL6A3 TNC LAMA2 NFASC DST COL14A1	5.23e-06	187	160	7	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IFT140 RNASEH2A PHKA2 AP4S1 PTPRB CCM2L SH3TC1	5.23e-06	187	160	7	3699d5e71d779da922920aa3160895db187bf81b
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IFT140 RNASEH2A PHKA2 AP4S1 PTPRB CCM2L SH3TC1	5.23e-06	187	160	7	033ba52c0c2f9978784947098fa697368ae44834
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C COL6A3 FRMPD4 TNC FAT3 SORCS3 COL14A1	5.60e-06	189	160	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPC1 TRIO ITGB8 IGF2BP2 DST PTPRJ SORCS3	5.60e-06	189	160	7	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPC1 TRIO ITGB8 IGF2BP2 DST PTPRJ SORCS3	5.60e-06	189	160	7	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HK3 IQGAP2 PSTPIP1 CRLF2 MYO1F DNAJC5 FMNL1	5.80e-06	190	160	7	ad297172a74a80ed5c10f921e15efd1da0fd2d6b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C COL6A3 FRMPD4 TNC FAT3 SORCS3 COL14A1	5.80e-06	190	160	7	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C COL6A3 FRMPD4 TNC FAT3 SORCS3 COL14A1	6.00e-06	191	160	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C COL6A3 FAT3 LAMA2 NFASC ITGA2 DST	6.00e-06	191	160	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C COL6A3 FRMPD4 TNC FAT3 SORCS3 COL14A1	6.21e-06	192	160	7	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	COPD-Lymphoid-T_Cytotoxic\|World / Disease state, Lineage and Cell class	MYH9 IQGAP2 STK17B SMCHD1 TBX21 ANKRD44 MCOLN2	6.21e-06	192	160	7	5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C COL6A3 FAT3 LAMA2 NFASC ITGA2 DST	6.21e-06	192	160	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C COL6A3 FRMPD4 TNC FAT3 SORCS3 COL14A1	6.21e-06	192	160	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	COVID-19-lung-CD4+_T_cells_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IQGAP2 STK17B SMCHD1 PSTPIP1 ANKRD44 MYO1F FMNL1	6.43e-06	193	160	7	326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C COL6A3 FRMPD4 TNC FAT3 SORCS3 COL14A1	6.43e-06	193	160	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C COL6A3 FRMPD4 TNC FAT3 SORCS3 COL14A1	6.65e-06	194	160	7	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IQGAP2 STK17B PSTPIP1 ANKRD44 MYO1F FMNL1 MCOLN2	6.65e-06	194	160	7	4dfc890bacf133cfb6ec7c8b73f084f2491cf78e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C COL6A3 FRMPD4 TNC FAT3 SORCS3 COL14A1	6.65e-06	194	160	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 TNC LAMA2 NFASC ATP10A DST COL14A1	6.87e-06	195	160	7	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C COL6A3 FAT3 LAMA2 NFASC IGF2BP2 DST	6.87e-06	195	160	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MGAM HK3 CFLAR S100A6 MYO1F G6PD FMNL1	7.11e-06	196	160	7	ad193b231ff2f7c72590fab79919c179d5d2f327
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRIO TNC GDF3 CHRNA3 DST PKD1 TENM1	7.11e-06	196	160	7	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MGAM HK3 CFLAR S100A6 MYO1F G6PD FMNL1	7.35e-06	197	160	7	8dd10962b6ba587512b2e68c762ade68c751cbc8
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MYH9 HK3 PSTPIP1 B4GALT5 S100A6 MYO1F G6PD	7.59e-06	198	160	7	3bc05b8d97a7219af40db7a11aa271f02e74fca5
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	CACNA1C COL6A3 TNC FAT3 LAMA2 NFASC COL14A1	7.59e-06	198	160	7	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C COL6A3 TNC FAT3 LAMA2 DST COL14A1	7.59e-06	198	160	7	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MGAM MYH9 PSTPIP1 S100A6 MYO1F G6PD FMNL1	7.85e-06	199	160	7	5919933c4b842b98fc98685dc8c72c8dd32c6ea3
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	CACNA1C COL6A3 TNC FAT3 LAMA2 DST COL14A1	7.85e-06	199	160	7	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYH9 HK3 PSTPIP1 B4GALT5 S100A6 MYO1F G6PD	7.85e-06	199	160	7	a1635a52318be0423f8e4fc03d971c28cd22b57e
ToppCell	LPS_only-Hematopoietic_Myeloid\|LPS_only / Treatment groups by lineage, cell group, cell type	MGAM HK3 CFLAR MYO1F MMP1 G6PD FMNL1	7.85e-06	199	160	7	20523dee39a4c5f6423259920f108127b47525c4
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	STK17B ATP10A STAT6 ANKRD44 BAZ1A MYO1F FMNL1	7.85e-06	199	160	7	155b03b859157013e9142e9248551369127d9204
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MGAM MYH9 PSTPIP1 S100A6 MYO1F G6PD FMNL1	7.85e-06	199	160	7	caf2e050b21e7a16ce4e51b3f135debd06810231
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ERBB2 TNC ITGA2 ITGB8 CELSR1 DST SCPEP1	8.11e-06	200	160	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC37A1 FOLH1 GRHL2 MYO5C SLC30A7 CELSR1 FAM177B	8.11e-06	200	160	7	c450a15e21fa72d071ed6e3b9f22de557a0f3cea
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL6A3 FAT3 LAMA2 NFASC DST COL14A1	8.11e-06	200	160	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL6A3 FAT3 LAMA2 NFASC DST MCOLN2	8.11e-06	200	160	7	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL6A3 TNC FAT3 LAMA2 ITGA2 COL14A1	8.11e-06	200	160	7	8c62f05c6042f24287a73fbdf80ff4a56f7ff403
ToppCell	mLN-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	IQGAP2 STK17B SMCHD1 INTS8 S100A6 BAZ1A SCPEP1	8.11e-06	200	160	7	e3c15e0e1c2602b0cc9ab8cc50c978d265350c94
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMNL2 ATP10A IGF2BP2 PTPRJ ATP6V0A4 DMBT1 MGAM2	8.11e-06	200	160	7	7c2d499af60654b7b28f172ac2c914ad49fb74b4
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL6A3 FAT3 LAMA2 NFASC DST COL14A1	8.11e-06	200	160	7	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MGAM HK3 CFLAR PTPRJ MYO1F MMP1 FMNL1	8.11e-06	200	160	7	fd1b6db3c62f5a205b769ba0e61433dae6285b67
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C COL6A3 FAT3 LAMA2 NFASC DST COL14A1	8.11e-06	200	160	7	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MGAM HK3 CFLAR PTPRJ MYO1F MMP1 FMNL1	8.11e-06	200	160	7	0b7573ec4e9c67c7d11dd8f5011a70bade30e930
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Interneuron\|1m / Sample Type, Dataset, Time_group, and Cell type.	EHBP1 HCN4 MYO7A CHRNA3 DST TENM1 DYNC1I2	8.11e-06	200	160	7	fc839e9c33ea1d4ee0f42f21fd32a54e7cbe1f5a
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C COL6A3 FAT3 PCDHB13 LAMA2 COL14A1	2.31e-05	158	160	6	e5636c0b608d68bd426a2b446ac508e4512e86a4
ToppCell	facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK17B GDF3 B4GALT5 PTPRJ MYO1F FMNL1	2.66e-05	162	160	6	484ea4ac40de672dcbd2583a52cb7f385c918814
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK17B GDF3 B4GALT5 PTPRJ MYO1F FMNL1	2.66e-05	162	160	6	bba144ac5332bab9eba2ccf599703c781a7f88f1
ToppCell	T_cells-TFH-like_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	COL6A3 ANK1 MYO7A INPP5F ITGB8 BBS12	2.85e-05	164	160	6	b10cf59f4cc37ca6cd0ecf71d7de278cc2bdd8b5
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 PSTPIP1 GDF3 MYO1F G6PD FMNL1	3.06e-05	166	160	6	82fa07632f7e586698fbf37381715b40f9f6ae3a
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 PSTPIP1 GDF3 MYO1F G6PD FMNL1	3.06e-05	166	160	6	0d03926452414f232c77fd15d5f48d148f9fca3b
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STK17B B4GALT5 PTPRJ MYO1F G6PD FMNL1	3.27e-05	168	160	6	c0aef5947b1d7e2c81a7481c509feda1687fcd7f
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STK17B B4GALT5 PTPRJ MYO1F G6PD FMNL1	3.27e-05	168	160	6	c861f80aa12caf54a94d93e38539ff41dc5227a6
ToppCell	Basal_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	FOLH1 TNC ITGA2 CBLN4 DST MMP1	3.27e-05	168	160	6	48089fa2d4a0f31a72405717119b767a92571f01
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ZNF407 ATP10A ANKRD44 CELSR1 DST EVI5L	3.38e-05	169	160	6	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ZNF407 ATP10A ANKRD44 CELSR1 DST EVI5L	3.38e-05	169	160	6	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HUS1B STK17B TBX21 PSTPIP1 GDF3 MYO1F	3.49e-05	170	160	6	c4f00c1acde1d3b521101e469101d10fd257653e
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HUS1B STK17B TBX21 PSTPIP1 GDF3 MYO1F	3.49e-05	170	160	6	d3c1edaf0190d8927578043c372dba7477e75e14
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	IQGAP2 PCDHGA5 SSTR1 PLEKHM2 MARF1 PCDHGA8	3.61e-05	171	160	6	6a2f88c2a62cb2f69797804e24eb1137a3e148de
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	IQGAP2 PCDHGA5 SSTR1 PLEKHM2 MARF1 PCDHGA8	3.61e-05	171	160	6	9be3554626408bb897d1f1c43b3ab4a92651f2e2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYH9 IQGAP2 STK17B SMCHD1 TBX21 CRLF2	3.61e-05	171	160	6	e1fe07652c10c37191d1471ddaea500f74269e0c
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PNLIP FAT3 GRHL2 MYO5C NR5A2 DMBT1	4.10e-05	175	160	6	3f1b2e23fec953148fb0711e523c463adb07dca4
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|normal_Lymph_Node / Location, Cell class and cell subclass	ANK1 IGF2BP2 DST DNAJC5 HEATR5B MCOLN2	4.24e-05	176	160	6	476794ef75ce5ab732d78cfeb4944e2f841e3e92
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK17B TBX21 ITGA2 PSTPIP1 MYO1F MCOLN2	4.24e-05	176	160	6	27c5ddd67de52101360ef7de8fcfa041066d97db
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HK3 SLC19A3 ATP10A SCPEP1 FMNL1 SLC27A3	4.51e-05	178	160	6	0b398656f26c4061b11ccf98908d0e2e1367585a
ToppCell	T_cells-TFH-like_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	COL6A3 ANK1 MYO7A INPP5F ITGB8 BBS12	4.51e-05	178	160	6	e2ae43e5ec31de6197f2cbd6089f944adbf0a163
ToppCell	LPS_only-Myeloid-Neutrophils\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM CFLAR ANKRD44 PTPRJ MYO1F MMP1	4.66e-05	179	160	6	d0a03e498afcfeb657037889685ecd77bed07e6c
ToppCell	LPS_only-Myeloid-Neutrophils-Neutrophils\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM CFLAR ANKRD44 PTPRJ MYO1F MMP1	4.66e-05	179	160	6	d034651a5a355a58f5e15db627869f4feebdfe35
Disease	MEHMO syndrome (implicated_via_orthology)	EIF2S3B EIF2S3	2.89e-05	2	159	2	DOID:0060801 (implicated_via_orthology)
Disease	Glycogen storage disease	PHKA1 PHKA2 AGL	9.88e-05	17	159	3	cv:C0017919
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1C CACNA1F	1.72e-04	4	159	2	DOID:0060173 (implicated_via_orthology)
Disease	Glycogen phosphorylase kinase deficiency	PHKA1 PHKA2	1.72e-04	4	159	2	cv:C0268147
Disease	Sarcosine measurement	PCDHGB2 PCDHGA5 PCDHGA8	2.51e-04	23	159	3	EFO_0021668
Disease	intermediate coronary syndrome (is_implicated_in)	ITGA2 MMP1	2.85e-04	5	159	2	DOID:8805 (is_implicated_in)
Disease	mental development measurement	PCDHGB2 PCDHGA5 PCDHGA8	3.24e-04	25	159	3	EFO_0008230
Disease	mean reticulocyte volume	MYH9 ANK1 GATAD2A IQGAP2 STK17B PCDHGA5 TBC1D16 ZBTB7A IGF2BP2 PTPRJ LPIN2 DNAJC5 SLC27A5	4.10e-04	799	159	13	EFO_0010701
Disease	hypopituitarism (implicated_via_orthology)	EIF2S3B EIF2S3	4.27e-04	6	159	2	DOID:9406 (implicated_via_orthology)
Disease	glucose metabolism disease (implicated_via_orthology)	HK3 EIF2S3B EIF2S3	4.56e-04	28	159	3	DOID:4194 (implicated_via_orthology)
Disease	Autosomal dominant nonsyndromic hearing loss	MYH9 MYO7A GRHL2	5.06e-04	29	159	3	cv:C5779548
Disease	Adenine measurement	CACNA1C GINM1	5.95e-04	7	159	2	EFO_0021573
Disease	sensorineural hearing loss (is_implicated_in)	MYH9 MYO7A ITGA2	7.44e-04	33	159	3	DOID:10003 (is_implicated_in)
Disease	Brugada syndrome	CACNA1C HCN4	7.91e-04	8	159	2	cv:C1142166
Disease	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO	CELSR1 TBXT	7.91e-04	8	159	2	C3891448
Disease	Autoinflammatory disorder	RNASEH2A PSTPIP1 LPIN2	8.85e-04	35	159	3	C3860213
Disease	lymphocyte count	ANK1 IQGAP2 PCDHGB2 PCDHGA5 TBX21 FMNL2 GRHL2 TBC1D16 ZBTB7A IGF2BP2 PTPRJ UMODL1 DMBT1 VWA2 BBS12 NEURL4 PCDHGA8 KDM4B	9.52e-04	1464	159	18	EFO_0004587
Disease	Nonsyndromic Deafness	MYO7A TNC GRHL2 MYO1F	9.78e-04	81	159	4	C3711374
Disease	leukodystrophy (implicated_via_orthology)	EIF2S3B EIF2S3	1.01e-03	9	159	2	DOID:10579 (implicated_via_orthology)
Disease	glycogen storage disease (is_implicated_in)	PHKA1 PHKA2	1.01e-03	9	159	2	DOID:2747 (is_implicated_in)
Disease	Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine	REC114 HCN4 LAMA2	1.04e-03	37	159	3	EFO_0004276, EFO_0004775, EFO_0006997
Disease	forced expiratory volume	DMGDH ANK1 PCDHGA5 CHRNA3 ITGB8 IGF2BP2 DST AGL NR5A2 ATXN3 RAB5B KDM4B	1.22e-03	789	159	12	EFO_0004314
Disease	retinitis pigmentosa (is_implicated_in)	IFT140 PRPF8 TULP1	1.41e-03	41	159	3	DOID:10584 (is_implicated_in)
Disease	Childhood Medulloblastoma	ERBB2 S100A6 KDM4B	1.62e-03	43	159	3	C0278510
Disease	Melanotic medulloblastoma	ERBB2 S100A6 KDM4B	1.62e-03	43	159	3	C1275668
Disease	Medullomyoblastoma	ERBB2 S100A6 KDM4B	1.62e-03	43	159	3	C0205833
Disease	Desmoplastic Medulloblastoma	ERBB2 S100A6 KDM4B	1.62e-03	43	159	3	C0751291
Disease	Adult Medulloblastoma	ERBB2 S100A6 KDM4B	1.62e-03	43	159	3	C0278876
Disease	eye disease	PCDHGA5 LAMA2 DYNC1I2	1.85e-03	45	159	3	EFO_0003966
Disease	schizophrenia, anorexia nervosa	CACNA1C GATAD2A CHRNA3	2.22e-03	48	159	3	MONDO_0005090, MONDO_0005351
Disease	lung adenocarcinoma (is_implicated_in)	ERBB2 CHRNA3 PTPRJ	2.36e-03	49	159	3	DOID:3910 (is_implicated_in)
Disease	Medulloblastoma	ERBB2 S100A6 KDM4B	2.50e-03	50	159	3	C0025149
Disease	autosomal dominant polycystic kidney disease (is_marker_for)	STAT6 MMP1	2.52e-03	14	159	2	DOID:898 (is_marker_for)
Disease	anemia (is_implicated_in)	ANK1 G6PD	2.52e-03	14	159	2	DOID:2355 (is_implicated_in)
Disease	thrombosis (is_implicated_in)	ITGA2 MMP1	2.89e-03	15	159	2	DOID:0060903 (is_implicated_in)
Disease	estradiol measurement	NSUN4 ZNF407 FBXO11 CELSR1	3.01e-03	110	159	4	EFO_0004697
Disease	hippocampal atrophy	SLC1A7 S100A6 ANKRD44	3.45e-03	56	159	3	EFO_0005039
Disease	Holoprosencephaly	PSTPIP1 FGF8	3.72e-03	17	159	2	C0079541
Disease	response to phenylephrine	IQGAP2 ATP10A	3.72e-03	17	159	2	EFO_0010152
Disease	muscular dystrophy (is_implicated_in)	COL6A3 LAMA2	3.72e-03	17	159	2	DOID:9884 (is_implicated_in)
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TRIO KDM4B	3.72e-03	17	159	2	DOID:0060307 (is_implicated_in)
Disease	renovascular hypertension (biomarker_via_orthology)	LAMA2 G6PD	4.65e-03	19	159	2	DOID:1591 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	HK3 FOLH1 IPP CUBN SLC1A7 DUSP21 SH3TC1 TENM1 MMP1 VWA2	4.89e-03	702	159	10	C0009402
Disease	carcinoma (implicated_via_orthology)	ERBB2 SLC30A7 RAB5B	5.03e-03	64	159	3	DOID:305 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
EVISVQVQDVNECFY	UMODL1	256	Q5DID0
GQVTRAQEAEENYVI	EVI5L	401	Q96CN4
LSFLQDIQEVQGYVL	ERBB2	71	P04626
LLFQQVQVEDGGVYT	AMIGO1	326	Q86WK6
QYVLGQDQQVDLTVA	C8orf74	126	Q6P047
NEVGQYDLEVTTFQL	CUL5	586	Q93034
IVLYNNAVGDFQVDD	CHRNA3	121	P32297
DEVVRELVNYGANVN	ANK1	91	P16157
TIQNGAEDVYETFNI	AQR	641	O60306
EQNYVVQVPEDVGLN	CELSR1	461	Q9NYQ6
ICQVFQIIYGDQSIE	CCM2L	321	Q9NUG4
QRLQFAFYVVEQVGT	B4GALT5	191	O43286
AEAAGAVQVAYITQV	BBS12	446	Q6ZW61
FIQNYVVSEGQLEDS	CFLAR	356	O15519
ALNITEDLGQIQYIF	ATP10A	411	O60312
YFVEETVEVIRNNGA	BAZ1A	116	Q9NRL2
GIIVVYDVTDQESFN	RAB1A	86	P62820
AQYITVQVPDGNIQE	REC114	141	Q7Z4M0
FSQYGEIVNINLVRD	RBMX2	56	Q9Y388
RGAQAAIVVYDITNQ	RAB5B	91	P61020
SEVQANNVVLGQYVG	G6PD	296	P11413
GNYQEVIQIFIEDNL	INTS8	336	Q75QN2
YTGIVNIGVNNVQEL	IPP	96	Q9Y573
VAVFQDQYGEFLELQ	OCEL1	166	Q9H607
IYGVEVEIIDINDNF	PCDHGA5	116	Q9Y5G8
VGVEEVQAFLQTYSQ	PCDHGA8	741	Q9Y5G5
EIIQSYIINIQAIEG	PCDHB18P	256	Q96TA0
QYAALFIVVGVNDTE	AP4S1	61	Q9Y587
NNEFIYLVGLEEVVQ	GATAD2A	381	Q86YP4
NLEQVEYVFLVIFTV	CACNA1F	126	O60840
NEGVYTAIAVQEIQG	PSTPIP1	341	O43586
TAQVYIEVLDVNDNA	PCDHB13	226	Q9Y5F0
TQAQGDVEFYQVLLI	PTPRB	576	P23467
IYQIENENTVDVYGI	PTPRJ	1256	Q12913
GSVEEFQGQEYLVII	MOV10L1	1091	Q9BXT6
NQVEQGEEQFLYTLT	GMEB1	326	Q9Y692
FLGNTPEQVVQEYLE	MGAM2	306	Q2M2H8
QNIRIVGAEVAYFVE	PNLIP	136	P16233
GVQFQNEAEIAGYIL	DST	421	Q03001
VVLNITYESGQVYVN	GINM1	61	Q9NU53
EVNFIQNLVFYIEAA	PHKA1	161	P46020
FLGNTPEQVVQEYLE	MGAM	351	O43451
FLAQLQQEGYSIFVV	ATXN3	151	P54252
NYISIINEDGNEIFN	FOLH1	126	Q04609
TNEQQQKVAETVGFY	SLC43A1	341	O75387
QELVSQGIEQVYAVR	CARF	426	Q8N187
EGQIVIYDVGEQIAV	DYNC1I2	591	Q13409
FQGAENAYTVNQVEL	FSIP2	3146	Q5CZC0
LALGQAVQFQEYVFL	GDF3	16	Q9NR23
GVQEYGTIQQDVTEA	FAM177B	141	A6PVY3
QTENFYDQIAVVSGV	KDELR3	171	O43731
YDQIAVVSGVVQTIF	KDELR3	176	O43731
YFVQVVIVANSGIIS	OR4K17	196	Q8NGC6
IVEETVGQYLSNINL	ODR4	6	Q5SWX8
IFYIAVIVQDINDNT	PCDHGB2	116	Q9Y5G2
QDYVAFVESLLQVQG	KDM4B	1076	O94953
YLLVTDQGFLQEEQV	MINDY1	331	Q8N5J2
VTQQNQIYVVGGLYV	KLHL41	341	O60662
ADVAQQFQYAVRVIG	TUBGCP3	26	Q96CW5
QIAAYGQVVFRLQEF	TUBGCP5	316	Q96RT8
ITLDLQQVFQIAYVI	LAMA2	126	P24043
INFDVNGYIVGANIE	MYH9	241	P35579
QDAVVNELIDYGANV	ANKRD44	251	Q8N8A2
LLAQYGTVENVEQVN	IGF2BP2	101	Q9Y6M1
AAEGVQIQIIYFNLE	CRLF2	26	Q9HC73
VAEQFGEENVNTYFV	DNAJC5	86	Q9H3Z4
AYNIDVVAVVNDTVG	HK3	211	P52790
VLYSVNENGNITVIQ	ITGA2	466	P17301
SGVFNYQENEIIQQI	HCN4	731	Q9Y3Q4
QNEYVVQGAIELLAN	NSUN4	316	Q96CB9
AVGVDNIFILVQAYQ	NPC1	696	O15118
SEVKVQVENQVQGIY	ITGB8	386	P26012
VNYQFRVIAINEVGS	NFASC	696	O94856
QTCENVVIVNQTYGI	CUBN	1276	O60494
VFTEIVLENNYTALQ	FGF8	146	P55075
GFYVVTQVINGLVQT	SLC37A1	156	P57057
VTGVVQQIVRAAQDY	HEATR5B	1661	Q9P2D3
FNTIGNIEEIAYNAV	GRHL2	341	Q6ISB3
FVGFVIVTFQEQGEQ	CACNA1C	1181	Q13936
AVAAIFIAQVNNYEL	SLC1A7	386	O00341
VIEENEVYSNTLAGV	FBXO11	606	Q86XK2
RIVYNNADGTEINEV	COL14A1	566	Q05707
EGIQFVENSVYANIG	FRMPD4	706	Q14CM0
EIGQDLIQVAVAQYA	COL6A3	476	P12111
YQAEVNENVDIGTSV	FAT3	1676	Q8TDW7
VEYLIQEQPGQEQVA	FEM1A	231	Q9BSK4
RIIYFDQILVNVGNF	CBLN4	91	Q9NTU7
VVVQAASGDVQTYQI	CREB1	226	P16220
VQIQAYLDNVFDVGA	FMNL2	366	Q96PY5
SQYVVGELAALENEQ	EHBP1	1071	Q8NDI1
GIDVQQVSLVINYDL	EIF4A2	336	Q14240
AYVPVQLSEVGQQVE	DMGDH	816	Q9UI17
YIAEFGDLEVVQENQ	MARF1	1031	Q9Y4F3
QLVLVQEDVSLQYFI	HUS1B	261	Q8NHY5
QVQIQAYLDNIFDVG	FMNL1	371	O95466
KEQYEQILAFVQGTV	EIF2S3B	201	Q2VIR3
NTIQVEEVQYGNFDV	DMBT1	2241	Q9UGM3
LDVLVNNAYAGVQTI	DHRS1	86	Q96LJ7
VNLNVERYALVFGIN	SLC19A3	396	Q9BZV2
QGFVQIEELVVNYTE	INPP5F	236	Q9Y2H2
NVQVGDLIYGQFVVA	EXOSC3	156	Q9NQT5
LARQYESQEEVGQAV	IFT140	1016	Q96RY7
VQGQYLTVEQLTLDF	DCAF15	436	Q66K64
VEVVNVFFEGIQYIK	DUSP21	56	Q9H596
NAQYVLVFDAFVIVI	MCOLN2	286	Q8IZK6
VVDLYGQAAQATIVD	NEURL4	671	Q96JN8
ADVYIENGIIQQVGR	DPYSL5	26	Q9BPU6
EVAFIQNLVFYIEAA	PHKA2	161	P46019
FLFNDILVYGNIVIQ	PLEKHF2	56	Q9H8W4
EVGSAQDSIFVYVLQ	PKD1	1616	P98161
GQQVAQTAEGQTIVY	NFYA	156	P23511
TAQVYIEVVDVNDNA	PCDHB8	226	Q9UN66
NELDYVSVGLDQQTV	PLEKHM2	656	Q8IWE5
EGVQEQVNAALLDYT	NR5A2	471	O00482
PFYVVQLVNVFAEQD	SSTR1	286	P30872
VVIIITDQYGNQIQA	SMCHD1	1171	A6NHR9
QEVNFQEYVTFLGAL	S100A6	66	P06703
QYALDQGVNVTQVFV	RNASEH2A	126	O75792
VQLAQDDIDGIQAIY	MMP1	246	P03956
IPQLVGEIYQNFFVE	SNX25	331	Q9H3E2
ISSLVVQDEYIFIQV	SORCS3	391	Q9UPU3
INVTVYNGQLDLIVD	SCPEP1	361	Q9HB40
VGLVDFVQEVNVYGV	SLC27A2	501	O14975
QIQEENDRVVAVGYI	IQGAP2	446	Q13576
VEQGVINNTVLGYFI	GARS1	396	P41250
DGNIVFVSENVTQYL	NCOA3	131	Q9Y6Q9
GDTVQFAEYIQKNVQ	PSMB2	51	P49721
VGEDNQETYLNISQV	STK17B	236	O94768
IFSANGQVIEVQYEI	TENM1	2101	Q9UKZ4
SELVDLYIQVAQNVA	SH3TC1	1086	Q8TE82
LAAIYQEIQETEQAI	MTRF1	116	O75570
FISLYVVQVNVEAVS	PIGW	351	Q7Z7B1
LLIQYVNNEGFSAVE	SLX4	716	Q8IY92
IEEQLEVVQQVVLYA	C12orf4	361	Q9NQ89
NVYVGFQVQLDLTGI	PRPF8	1546	Q6P2Q9
QELAAVIYETNVLGF	TULP1	401	O00294
QELINSIEQVYFSVD	VPS50	51	Q96JG6
IVETAQVQIGLRYNA	WWC2	696	Q6AWC2
FILDNVQVVLQQTYG	REV1	1231	Q9UBZ9
ALDFLQEVNVYGVTV	SLC27A3	566	Q5K4L6
LSQVDFLQQVNVYGV	SLC27A5	571	Q9Y2P5
LVDIYSQLQQEVGAA	STAT6	231	P42226
VAIVAIYGDDVIEQQ	TBC1D16	646	Q8TBP0
IYGDDVIEQQLATDQ	TBC1D16	651	Q8TBP0
GTYDQFTIQVQEADQ	TNC	1281	P24821
FEVNPDVTQVGLVVY	VWA2	561	Q5GFL6
DVTQVGLVVYGSQVQ	VWA2	566	Q5GFL6
QFIAVTAYQNEEITA	TBXT	191	O15178
QVTYRVVQVTDGQLD	USF2	76	Q15853
GEQYVVIIQNKIDIY	PAK1IP1	176	Q9NWT1
ESDIYIVANEEGQQF	RIOK2	106	Q9BVS4
QAGVRQLYVQIDFAA	SLC30A7	361	Q8NEW0
EIQKNIFIIFYQGEQ	ATP6V0A4	216	Q9HBG4
DQLFIYETAGVLIVN	XPOT	591	O43592
EQVQQVIIFQGYDGE	ZNF407	1861	Q9C0G0
INVVDELAIQFYEIQ	WHAMMP3	106	Q1A5X7
ETQFIAVTAYQNAEI	TBX21	296	Q9UL17
GAVVDQQNVYEIDFV	ZBTB7A	66	O95365
DLLQYVNEVQASGVE	TRIO	851	O75962
GFIQVYVDQVDEDIV	AGL	716	P35573
KEQYEQILAFVQGTV	EIF2S3	201	P41091
IDVIVVQQQDGSYQC	LPIN2	31	Q92539
QYVGQDVDELSFNVN	MYO1F	1051	O00160
YTEISFDEQNQIIGA	MYO5C	221	Q9NQX4
TGVYFVDEQEQVLLE	MYO7A	1496	Q13402